It is currently Wed Jul 01, 2015 5:58 am

News News of Tcelna (Tovaxin)

Site map of Tcelna (Tovaxin) » Forum : Tcelna (Tovaxin)

A board to discuss Tcelna as a treatment for Multiple Sclerosis

RESULTS WILL VARY!

Hi to all,

I cannot believe that some people are looking for results like I have had while on Tovaxin. That these people think they may be on placebo just because they have not seen similar improvements. I don’t think these people ever read my timeline, and if they did, they only saw what they wanted to see.

I have said over 100 times that the hope for Tovaxin is to stop the attacks. There ...
Read more : RESULTS WILL VARY! | Views : 23970 | Replies : 144


Tovaxin News

Greetings,
This recent press release from Opexa suggests that they may be improving their methods of making the vaccine. Hopefully, this will increase the efficacy of the current vaccine and, in the future, help get people into the Phase III study more quickly once it begins.

NHE

Opexa Presents Tovaxin™ Research at Federation of Clinical Immunology Societies Annual Meeting
June 11, 2007 07:00 AM Eastern Daylight Time

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a ...
Read more : Tovaxin News | Views : 1936 | Replies : 1


Tovaxin Users

Member havingms has proposed we put together an informational thread for Tovaxin users. If you are on/have been on Tovaxin therapy, please consider answering the following questions in this thread for the benefit of others.

Thanks!


• When did you receive your first vaccination?

• What dose did you receive? How many millions of cells?

• What was your overall experience? Did you get better or worse?

• What side effects did you notice?
Read more : Tovaxin Users | Views : 32312 | Replies : 96


Dr Zang

I think this article is about the Dr Zang who developed the T cell vaccination. Interesting that GSK have snapped him up - they are one of the big players.

GlaxoSmithKline Launches Chinese R&D Centre with Appointment of Head in Shanghai 24 May 2007

Jingwu Zang to lead work on neurogenerative diseases.


GlaxoSmithKline (GSK) today announced the appointment of Jingwu Zang to head a new GSK research and development centre in Shanghai, China. His ...
Read more : Dr Zang | Views : 2798 | Replies : 6


Greetings from Europe and waiting for tovaxin to start there

Hi everybody and congratulations for this very interesting forum.

I'm french and my girlfriend was recently diagnosed with MS. (we're both 22) My whole world was crushed away in two weeks as many of our life projects were questioned because of MS.

I started searching the Internet all I could find about the disease, especially treatments, and I eventually heard about Tovaxin, which seems to me very promising. Unfortunately, we're french and there's no tovaxin ...
Read more : Greetings from Europe and waiting for tovaxin to start there | Views : 2667 | Replies : 6


My Tovaxin Experience so far

Howdy all,

I have been watching what has been going on here at the Tovaxin forum with great interest but have remained silent on how things are going for me in the study. I received my third injection last Thursday so here is how things have gone for me.

I went in for my first treatment on March 23 and the whole deal was uneventful. As a side note, it was very important that the ...
Read more : My Tovaxin Experience so far | Views : 10211 | Replies : 59


T-Cell vaccines

I know its a tovaxin forum, and i know its had a higher published success rate, but why is it that there are so many people excited about a phase IIb treatment (Tovaxin) over a similar treatment (in my understanding of the theorys) already in Phase 3 ??

If / Once it gets to market, I am sure they will improve its effectiveness to close to that of ...
Read more : T-Cell vaccines | Views : 4148 | Replies : 15


Opexa Completes Patient Enrollment in Phase IIb

http://www.genengnews.com/news/bnitem.aspx?name=17568660
Opexa Therapeutics Completes Patient Enrollment in Phase IIb Trial of Tovaxin(TM) for Treatment of Multiple Sclerosis
May 17 2007, 7:00 AM EST
Business Wire


Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company involved in the development and commercialization of cell therapies, today announced the completion of patient enrollment in a 150-patient Phase IIb safety and efficacy study (TERMS). The trial design is a U.S. multicenter, randomized, double-blind, placebo-controlled study of subcutaneous Tovaxin(TM) in subjects with Clinically ...
Read more : Opexa Completes Patient Enrollment in Phase IIb | Views : 2226 | Replies : 7


Last (booster) shot today!

Well I got my last injection today. It was uneventful as they all are. My coordinator told me that they had to color the placebo too as people were peeking and they are different colors. Hell for all I know that's just what they told me to make me not turn around. Now comes the six months of waiting to get into the extension. I get an MRI in four weeks and then some more ...
Read more : Last (booster) shot today! | Views : 2125 | Replies : 8


First injection of Tovaxin?/placebo

Hi again everybody. Well, my much delayed first injection happened yesterday. I was a bit discouraged at first since I saw absolutely no site reaction on either arm. But my wife comforted me with her words that "God knows what's best for you" which I know is true and that we just need to continue trusting in Him. My next injection is scheduled for the end of this month. I wish everyone better health, both ...
Read more : First injection of Tovaxin?/placebo | Views : 2819 | Replies : 13


 

Login  •  Register


Statistics

Total posts 226223 • Total topics 23788 • Total members 15094


Contact us | Terms of Service